PPD
PPD, a clinical research business of Thermo Fisher Scientific, is a leading provider of global contract research organization (CRO) solutions. The company is dedicated to helping clients accelerate the development of life-changing therapies through comprehensive drug development, laboratory, and lifecycle services. With a commitment to operational excellence and innovative technology, PPD empowers its customers to bring therapies to market faster and improve patient health. PPD has been recognized as an industry leader in clinical development digital transformation services and patient engagement digital transformation. With over 30 years of clinical leadership and a workforce of more than 30,000 employees globally, PPD has conducted over 2,100 trials in the past five years.
Industries
Nr. of Employees
Very Large (1000+)
Awards
PPD PTSD APT Proposal Focus Areas 1, 2, 3
Funding (ceiling)
$43,281,282.88
Award Year
2020
Products
GMP Laboratory Services
Provides analytical services for small molecules and biologics, including testing for APIs, drug products, and medical devices across all phases of drug development.
Preclarus Lab Solutions
Offers a suite of tools for data integration and management to enhance clinical trial performance and regulatory success.
Regulatory Affairs Solutions
Provides end-to-end regulatory services to navigate global regulatory environments and accelerate product approval.
Decentralized Clinical Trials (DCT)
Facilitates clinical trials using telemedicine and remote monitoring to improve recruitment and retention while ensuring data quality.
Accelerated Enrollment Solutions (AES)
Offers a network of global sites and patient data to streamline clinical trial recruitment and reduce timelines.
Integrated Clinical Development Consulting
Offers strategic consulting services across clinical development, regulatory strategy, and trial design to optimize drug development.
GMP Laboratory Services
Provides analytical services for small molecules and biologics, including testing for APIs, drug products, and medical devices across all phases of drug development.
Preclarus Lab Solutions
Offers a suite of tools for data integration and management to enhance clinical trial performance and regulatory success.
Regulatory Affairs Solutions
Provides end-to-end regulatory services to navigate global regulatory environments and accelerate product approval.
Decentralized Clinical Trials (DCT)
Facilitates clinical trials using telemedicine and remote monitoring to improve recruitment and retention while ensuring data quality.
Accelerated Enrollment Solutions (AES)
Offers a network of global sites and patient data to streamline clinical trial recruitment and reduce timelines.
Integrated Clinical Development Consulting
Offers strategic consulting services across clinical development, regulatory strategy, and trial design to optimize drug development.
Expertise Areas
- Clinical trial management (Phase I–IV)
- Early-phase and adaptive trial design
- Decentralized and hybrid clinical trials
- Clinical data management and integration
Key Technologies
- Polymerase chain reaction (PCR)
- Electronic data capture (EDC) and eSource
- ePRO / eCOA platforms
- AI / machine learning for trial analytics
Investors
GIC
Announced on 2017-04-27.
GIC
Announced on 2017-04-27.
News & Updates
Meet with our team at the ASH Annual Meeting in San Diego, California, on Dec. 7-9, 2024.
A survey of 150 leaders at biotech and pharmaceutical organizations assessing trends, challenges, and sentiments in drug discovery and development.
Insights from 150 global drug development leaders illuminate industry trends, challenges, and sentiments.
PPD was named 'Best Vaccine CRO of the Year' at the Asia Pacific Vaccine Excellence Awards 2023, recognizing its contributions to vaccine development.
For the 12th consecutive year, PPD received the CRO Leadership Award, recognizing excellence in various categories.
PPD was recognized by ISG as a leader in clinical development digital transformation services and patient engagement digital transformation.
Meet with our team at the ASH Annual Meeting in San Diego, California, on Dec. 7-9, 2024.
A survey of 150 leaders at biotech and pharmaceutical organizations assessing trends, challenges, and sentiments in drug discovery and development.
Insights from 150 global drug development leaders illuminate industry trends, challenges, and sentiments.
PPD was named 'Best Vaccine CRO of the Year' at the Asia Pacific Vaccine Excellence Awards 2023, recognizing its contributions to vaccine development.
For the 12th consecutive year, PPD received the CRO Leadership Award, recognizing excellence in various categories.
PPD was recognized by ISG as a leader in clinical development digital transformation services and patient engagement digital transformation.